IMCLISFAPriority claimed from 06/11/2023; Application No. : 98257351 ;United States of America (Class 5)
#6416013
Application Number:6416013
Status: Unknown
Class:5
Applicant:Ideaya Biosciences, Inc.
Filing Date:Fri, 03 May 2024
In Progress
Is this your trademark application?
"IMCLISFAPriority claimed from 06/11/2023; Application No. : 98257351 ;United States of America" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.
Trademark Information
| Trademark | IMCLISFAPriority claimed from 06/11/2023; Application No. : 98257351 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 6416013 |
| Nature/Scope of business | Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; Therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes. |
| Publication | In Journal No. 2201 |
| Status | Unknown |
| Applicant: | Ideaya Biosciences, Inc. |
| Applicant Address | 7000 Shoreline Ct, Suite 350, South San Francisco, California 94080, United States Of America A Delaware Corporation |
| Jurisdiction | DELHI |
| Agent | LALL & SETHI |
| Agent Address | D-17, South Extension Part II, New Delhi 110049, India |
Frequently Asked Questions
Who is the owner of trademark IMCLISFAPriority claimed from 06/11/2023; Application No. : 98257351 ;United States of America? ▾
The trademark application number 6416013 is owned by Ideaya Biosciences, Inc..
Which class does trademark IMCLISFAPriority claimed from 06/11/2023; Application No. : 98257351 ;United States of America belong to? ▾
Trademark application number 6416013 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 6416013? ▾
The trademark agent associated with application number 6416013 is LALL & SETHI.
Was trademark IMCLISFAPriority claimed from 06/11/2023; Application No. : 98257351 ;United States of America published in the journal? ▾
Yes, trademark application number 6416013 was published in Journal No. 2201.
What is trademark IMCLISFAPriority claimed from 06/11/2023; Application No. : 98257351 ;United States of America? ▾
Trademark application number 6416013 relates to "Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; Therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes.".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified